Literature DB >> 20056249

Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.

Giovanni Piccolo1, Eleonora Tavazzi, Tiziana Cavallaro, Alfredo Romani, Roberto Scelsi, Gianvito Martino.   

Abstract

OBJECTIVE: To report clinical and pathological findings of a patient with late onset insulin-dependent diabetes mellitus (IDDM), progressive cerebellar ataxia (PCA) and hepatocellular carcinoma (HCC). PATIENT: A 64-year-old woman, with a long lasting IDDM, progressively developed a severe cerebellar syndrome and died 2 years after the onset of the symptoms for a systemic infection. Autoantibodies to antigastric parietal cell and anti-pancreatic islet cell resulted positive. Autopsy showed a selective loss of Purkinje cells in the cerebellum, with an increase of Bergmann glia and variable microglial proliferation; furthermore, it disclosed an HCC. GAD-Abs were detected both in serum and CSF.
CONCLUSIONS: Clinical and experimental reports suggest a possible role of neoplastic cells in producing GAD-Abs. We postulate, in our case, that HCC could have been responsible for an overproduction of GAD-Abs, leading to the onset of PCA. Thus, GAD-Abs could be considered as a paraneoplastic marker in a subgroup of patients with PCA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056249     DOI: 10.1016/j.jns.2009.12.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 2.  Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

Review 3.  Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Nicolás Lundahl Ciano-Petersen; Macarena Villagrán-García; Bastien Joubert; Jérôme Honnorat
Journal:  Cerebellum       Date:  2022-01-12       Impact factor: 3.648

4.  GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors:  Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal:  J Neurol       Date:  2013-10-05       Impact factor: 4.849

5.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors:  Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

6.  [Effect of acupuncture pretreatment on action potential of cerebellar Purkenje cells in ex vivo ischemic rat brain slices].

Authors:  Li Huang; Chun Wang; Yan Li; Shi-di Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

Review 7.  'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 8.  Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Mario Manto; Christiane S Hampe
Journal:  J Immunol Res       Date:  2017-03-12       Impact factor: 4.818

Review 9.  Immune-mediated cerebellar ataxias: from bench to bedside.

Authors:  Hiroshi Mitoma; Mario Manto; Christiane S Hampe
Journal:  Cerebellum Ataxias       Date:  2017-09-21

Review 10.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.